iomeprol has been researched along with Cancer of Ovary in 3 studies
iomeprol: structure given in first source
iomeprol : A benzenedicarboxamide compound having N-substituted carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and a glycoloyl(methyl)amino group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maurin, C | 1 |
| Vassal, O | 1 |
| Darien, M | 1 |
| Raba, M | 1 |
| Allaouchiche, B | 1 |
| Piriou, V | 1 |
| Diaz-Gil, D | 1 |
| Fintelmann, FJ | 1 |
| Molaei, S | 1 |
| Elmi, A | 1 |
| Hedgire, SS | 1 |
| Harisinghani, MG | 1 |
| Kitajima, K | 1 |
| Murakami, K | 1 |
| Yamasaki, E | 1 |
| Domeki, Y | 1 |
| Kaji, Y | 1 |
| Fukasawa, I | 1 |
| Inaba, N | 1 |
| Suganuma, N | 1 |
| Sugimura, K | 1 |
1 review available for iomeprol and Cancer of Ovary
| Article | Year |
|---|---|
Immune hemolysis secondary to injection of contrast medium.
Topics: Adult; Anemia, Hemolytic; Antibody Specificity; Catecholamines; Combined Modality Therapy; Contrast | 2018 |
2 other studies available for iomeprol and Cancer of Ovary
| Article | Year |
|---|---|
Prediction of 5-year survival in advanced-stage ovarian cancer patients based on computed tomography peritoneal carcinomatosis index.
Topics: Aged; Biomarkers, Tumor; CA-125 Antigen; Contrast Media; Cytoreduction Surgical Procedures; Female; | 2016 |
Performance of integrated FDG-PET/contrast-enhanced CT in the diagnosis of recurrent ovarian cancer: comparison with integrated FDG-PET/non-contrast-enhanced CT and enhanced CT.
Topics: Adult; Aged; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Iopamidol; Male; Middle Aged; N | 2008 |